All
Susan Sabo-Wagner Cites Challenges With Home Care for Patients With Cancer
December 26th 2022Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, discussed how housing conditions can impede positive outcomes for patients with cancer who are receiving cancer care support at home.
Read More
Neoadjuvant Immunotherapy Promising in CRC, but Long-term Data Needed, Says Dr Kristen Ciombor
December 24th 2022Kristen K Ciombor, MD, MSCI, associate professor at Vanderbilt University, explains that results of neoadjuvant immunotherapy in colorectal cancer are promising, but long-term data is still needed.
Read More
Biosimilars Are a "Wonderful" Option for Patients With Cancer, Says Susan Sabo-Wagner
December 23rd 2022Biosimilars are a wonderful option for patients, but the growing number available can be challenging to manage when different payers prefer different agents, said Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.
Read More
Different Types of Support Are Essential for Home Cancer Care, Says Susan Sabo-Wagner
December 20th 2022Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas, talked about the importance of having adequate support not only from clinical staff, but also emotional and moral support at home.
Read More
Dr Kyle Lamb Discusses Transitional Care, Super-Utilization in Value-Based Medicine
December 19th 2022Kyle Lamb, MD, associate medical director of population health at Vancouver Clinic, discusses how super-utilization trends have changed since the start of COVID-19, the necessity of transitional care in implementing value-based medicine, and how technology can decrease super-utilization.
Read More
Dr Martin Levine Explains the Growing Need for Caregiver Support in Alzheimer Disease
December 19th 2022Martin Levine, MD, MBA, chief medical officer at the PolyClinic at Optum Washington, describes why caregivers need more resources to adequately manage patients with Alzheimer disease and what clinics can do to ensure access to those resources.
Read More
Value-Based Primary Care Providers Try New Strategies to Improve Population Health
December 15th 2022The dilemma of Alzheimer disease in primary care, as well as other health challenges in aging populations, was the focus of a recent Institute for Value-Based Medicine® event in Portland, Oregon.
Read More
How Ochsner, Xavier Are Working Together to Make Louisiana a Healthy State
December 15th 2022Leaders from Ochsner, Xavier, and their partners gathered on September 13, 2022, in New Orleans to offer an overview of the Healthy State initiative during a session of the Institute for Value-Based Medicine®.
Read More
Aligning Payers and Providers for Value-Based Cancer Care Payments
December 9th 2022Lucy Langer, MD, MSHS, national medical director, oncology and genomics, MSHS, national medical director, oncology and genomics, UnitedHealthcare, discussed value-based contracting at the IVBM® session October 5, 2022.
Read More
Dr Samyukta Mullangi: COVID-19 Has Spurred Us to Ask How We Can Innovate Care Delivery
December 1st 2022During an Institute for Value-Based Medicine® event held in New York City, Samyukta Mullangi, MD, MBA, fellow in medical oncology at Memorial Sloan Kettering Cancer Center, discussed how disruptions from the COVID-19 pandemic are ushering in health care delivery reform.
Read More
Dr Emeline Aviki: Telehealth Allows Patients a Quick Return to Daily Life
November 19th 2022There is a major role for telehealth in oncology care, not only for its convenience but also for giving clinicians the ability to scale nononcologic visits, explained Emeline Aviki, MD, MBA, FACOG, assistant attending gynecologic cancer surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and lead of the MSKCC Affordability Working Group.
Read More
Dr Stephen Schleicher: We Need to Focus More on Financial Toxicity
November 14th 2022Stephen M. Schleicher, MD, MBA, chief medical officer at Tennessee Oncology, addresses the “huge problem” of financial toxicity among patients with cancer, which can be attributed in part to both the high price of targeted treatments and even from ordering only necessary testing.
Read More
Dr Timothy Murphy: Strong Communication Is Necessary for Practices Stocking Multiple Biosimilars
November 13th 2022With multiple biosimilars approved for a reference product and different payers preferring particular products, communication between the clinical pharmacy team and the managed care team is crucial, said Timothy Murphy, MD, FACP, medical oncologist/hematologist with Rocky Mountain Cancer Centers.
Read More
Meet Dr Ishani Ganguli, Seema S. Sonnad Emerging Leader in Managed Care Research Award Recipient
November 10th 2022Ishani Ganguli, MD, MPH, assistant professor of medicine at Harvard Medical School, physician at Brigham and Women’s Hospital, reacts to receiving the 2022 Seema S. Sonnad Emerging Leader in Managed Care Research Award.
Read More
Dr Neil Iyengar Emphasizes Importance of Population Health Lens in Oncology at PCOC 2022
November 10th 2022Population health brings an important lens to both oncology practice and research, said Neil Iyengar, MD, associate attending physician, breast medical service, Memorial Sloan Kettering Cancer Center.
Read More
Dr Timothy Murphy Discusses Successfully Implementing Biosimilars Into Community Cancer Practice
October 28th 2022Having a plan in place to educate providers and the pharmacy team has contributed to the success that Rocky Mountain Cancer Centers (RMCC) has had with rapidly implementing biosimilars, said Timothy Murphy, MD, medical oncologist/hematologist with RMCC.
Read More
Lessons From the Pandemic to Scale Cancer Care Innovation
October 21st 2022Coverage from the New York City presentation of the Institute for Value-Based Medicine, co-chaired by Emeline Aviki, MD, MBA, of Memorial Sloan Kettering Cancer Center (MSKCC), and Robert Daly, MD, MBA, medical oncologist and lung cancer specialist at MSKCC.
Read More
Advances in Cancer Care Demand Access for All, City of Hope Leaders Say
October 21st 2022Coverage from the Irvine, California, meeting of the Institute for Value-Based Medicine, chaired by Joseph Alvarnas, MD, vice president for government affairs at City of Hope and chief clinical advisor, AccessHope.
Read More